Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

百因止 - NMPA Drug Approval Details

Approvals/NMPA/Recombinant Coagulation Factor VIII for Injection

Approved

生物制品

Recombinant Coagulation Factor VIII for Injection

Takeda Manufacturing Austria AG🇨🇳 National Medical Products Administration

Approval Date: Dec 20, 2023
Approval ID: 8Iee18PXZ88
Company: Takeda Manufacturing Austria AG
Type: 生物制品

Approval Details

Approval Id: 8Iee18PXZ88
Approval Number: 国药准字SJ20170021
Generic Name: 注射用重组人凝血因子Ⅷ
Generic Name En: Recombinant Coagulation Factor VIII for Injection
Trade Name: 百因止
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 500IU/瓶
Reg Date: 2023-12-20
Expired Date: 2027-07-28
Company Name: Takeda Manufacturing Austria AG
Production Company Name: Baxalta Manufacturing Sàrl
Company Detail Path: /organization/cf6564b544e300bc/takeda-manufacturing-austria-ag
Production Company Detail Path: /organization/98223afe19605180/baxalta-manufacturing-sarl

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 20, 2023

Approval ID

8Iee18PXZ88

Type

生物制品

Back to NMPA Approvals